Organisation paid for research Program year 2023 Source: CMS Open Payments

CITrials Bellflower

Neither a doctor nor a teaching hospital

Research payments

$520

10 payments

Through program year 2023, CITrials Bellflower is reported as receiving $520 in research payments, across 10 payments.

By program year

2 rows
Year Kind Amount Payments
2023 Research $150 3
2022 Research $370 7

Breakdown

Who paid Research payments · program years 2022–2023
  1. Sunovion Pharmaceuticals Inc. $370 7 payments
  2. Sumitomo Pharma America, Inc. $150 3 payments
Studies the money was for Research payments · program years 2022–2023
  1. A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia $370 7 payments
  2. A Randomized Double-blind Parallel-group Placebocontrolled Fixed-dose Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Subjects with Schizophrenia $150 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record